THAP6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.136600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.084000E-01
Normal-vs-Stage2
4.531000E-01
Normal-vs-Stage3
2.276000E-01
Normal-vs-Stage4
7.383800E-01
Stage1-vs-Stage2
2.781800E-02
Stage1-vs-Stage3
2.120100E-03
Stage1-vs-Stage4
7.281600E-01
Stage2-vs-Stage3
4.291600E-02
Stage2-vs-Stage4
5.765400E-01
Stage3-vs-Stage4
1.993440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.413210E-01
Normal-vs-AfricanAmerican
2.700200E-01
Normal-vs-Asian
3.552400E-01
Caucasian-vs-AfricanAmerican
7.713800E-01
Caucasian-vs-Asian
1.796010E-01
AfricanAmerican-vs-Asian
4.552600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.656800E-01
Normal-vs-Female
1.744620E-01
Male-vs-Female
5.574800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.870600E-01
Normal-vs-Age(41-60Yrs)
2.606400E-01
Normal-vs-Age(61-80Yrs)
8.426100E-02
Normal-vs-Age(81-100Yrs)
1.089840E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.350800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.305200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.380990E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.981900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.399180E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.352800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.091000E-01
Normal-vs-Daily Drinker
4.237800E-01
Normal-vs-Weekly Drinker
1.665350E-01
Normal-vs-Occasional Drinker
5.032400E-01
Normal-vs-Social Drinker
6.623000E-01
Non Drinker-vs-Daily Drinker
8.781800E-01
Non Drinker-vs-Weekly Drinker
9.567000E-01
Non Drinker-vs-Occasional Drinker
3.184400E-01
Non Drinker-vs-Social Drinker
4.270400E-02
Daily Drinker-vs-Weekly Drinker
9.505200E-01
Daily Drinker-vs-Occasional Drinker
4.498200E-01
Daily Drinker-vs-Social Drinker
4.446300E-02
Weekly Drinker-vs-Occasional Drinker
4.995600E-01
Weekly Drinker-vs-Social Drinker
9.502000E-02
Occasional Drinker-vs-Social Drinker
1.579580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.133810E-01
Normal-vs-Grade 2
6.496200E-03
Normal-vs-Grade 3
9.202500E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.962200E-01
Grade 1-vs-Grade 3
9.308800E-01
Grade 1-vs-Grade 4
1.133810E-01
Grade 2-vs-Grade 3
6.656000E-02
Grade 2-vs-Grade 4
6.496200E-03
Grade 3-vs-Grade 4
9.202500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.989800E-01
Normal-vs-NonDiabetic
1.087830E-01
Diabetic-vs-NonDiabetic
2.447400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.412600E-01
Normal-vs-NoPancreatitis
8.285900E-02
Pancreatitis-vs-NoPancreatitis
4.493000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.892600E-01
Normal-vs-N1
4.391400E-01
N0-vs-N1
1.073170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.231000E-01
Normal-vs-TP53-NonMutant
4.825000E-01
TP53-Mutant-vs-TP53-NonMutant
6.012400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
